Terns Pharmaceuticals (TERN) Profit After Tax (2020 - 2023)
Historic Profit After Tax for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to -$21.0 million.
- Terns Pharmaceuticals' Profit After Tax fell 3284.67% to -$21.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$90.2 million, marking a year-over-year decrease of 4949.04%. This contributed to the annual value of -$88.9 million for FY2024, which is 150.43% up from last year.
- Per Terns Pharmaceuticals' latest filing, its Profit After Tax stood at -$21.0 million for Q4 2023, which was down 3284.67% from -$29.8 million recorded in Q3 2023.
- Terns Pharmaceuticals' 5-year Profit After Tax high stood at -$9.2 million for Q1 2020, and its period low was -$29.8 million during Q3 2023.
- Moreover, its 4-year median value for Profit After Tax was -$13.9 million (2022), whereas its average is -$15.1 million.
- In the last 5 years, Terns Pharmaceuticals' Profit After Tax crashed by 210.51% in 2021 and then plummeted by 7697.38% in 2023.
- Terns Pharmaceuticals' Profit After Tax (Quarter) stood at -$9.9 million in 2020, then plummeted by 43.5% to -$14.2 million in 2021, then fell by 11.05% to -$15.8 million in 2022, then crashed by 32.85% to -$21.0 million in 2023.
- Its Profit After Tax stands at -$21.0 million for Q4 2023, versus -$29.8 million for Q3 2023 and -$17.9 million for Q2 2023.